Oral or injectable semaglutide: what’s the difference?

Semaglutide as a tablet or injection: what’s the difference?

Short answer: Semaglutide as an injection (Wegovy) leads, on average, to greater weight loss than the tablet (Rybelsus), but the tablet is a perfectly valid alternative for those who wish to avoid injections. A doctor will decide which form is best suited to you.

Semaglutide is available in two forms: as a weekly injection (Wegovy) and as a daily tablet (Rybelsus). Both suppress appetite via the same mechanism, but they differ significantly in terms of how the body absorbs them, how effective they are for weight loss, and what the practical advantages and disadvantages are. In this blog, you can read what semaglutide (Ozempic) is, how the two forms compare, and which choice Goodweigh will make together with you.

What is the difference between oral and injectable semaglutide?

The main technical difference lies in how the medicine is absorbed by the body. Subcutaneous semaglutide has a bioavailability of approximately 89 per cent, meaning that almost the entire dose enters the bloodstream. With the tablet, it is quite different: bioavailability is only 1 to 2 per cent, and in a small group of patients, it is even close to zero. According to Farmacotherapeutisch Kompas, absorption is so unpredictable that oral GLP-1 agonists are not preferred over subcutaneous formulations, particularly in patients at high cardiovascular risk.

To compensate for the low absorption, Rybelsus (oral semaglutide) contains the excipient SNAC, which facilitates absorption through the stomach wall. However, this only works under strict conditions: the tablet must be taken on an empty stomach with no more than 120 ml of water, and the patient must then wait at least 30 minutes before eating, drinking or taking any other medication. These restrictions do not apply to the injection.

Rybelsus is authorised for the treatment of type 2 diabetes, not primarily for weight loss. The high-dose injectable semaglutide (Wegovy 2.4 mg/week) is the only one that has official authorisation for the treatment of obesity and overweight in adults. This distinction is also relevant to reimbursement: the indication for which semaglutide is used determines whether reimbursement is granted.

Which form is most effective for weight loss?

Injectable semaglutide results in greater weight loss on average, although the difference is smaller than one might expect. A large phase 3 study shows that oral semaglutide 25 mg in overweight individuals led to an average weight loss of 13.6% over 68 weeks. This is an impressive result. Nevertheless, a meta-analysis of 12 randomised studies (n=6,253) shows that injectable semaglutide results in an average weight loss of 2.19 kg more than the oral form. How much weight you can lose with semaglutide also depends to a large extent on your starting weight, lifestyle and how consistently you follow the treatment.

Below is an overview of the key differences.

Oral vs. injectable semaglutide: overview

Based on the current state of research, the injectable form is clearly preferable if the aim is maximum efficacy. Nevertheless, oral semaglutide performs far better than placebo and better than subcutaneous liraglutide: the PIONEER 4 study shows that oral semaglutide 14 mg led to a weight loss of 4.4 kg compared with 3.1 kg for subcutaneous liraglutide.

What are the advantages of the tablet?

The main advantage is practical: no needles, no fear of injections, no need to store pens in the fridge. For people who absolutely do not want injections, Rybelsus (oral semaglutide) is a serious alternative. The tablet also fits more easily into a morning routine without any medical intervention.

Furthermore, some people are already achieving very good results with the tablet. The higher doses (25 mg), which have recently been studied, show that the difference in efficacy compared with the injection becomes smaller the higher the dose you go up to. For people with mild obesity or who are overweight, the tablet may be sufficient to reach their weight target.

What are the benefits of the injection?

Wegovy (high-dose semaglutide injection) provides a far more predictable effect. Its high bioavailability of ~89% means that the active dose is consistently absorbed by the body, regardless of when you eat or what other medicines you are taking. This also makes it easier for the treating doctor to optimise the dosage.

Wegovy is also the only semaglutide formulation shown to reduce cardiovascular risk in obesity, as demonstrated in the SELECT study. Real-world studies show that treatment adherence after 18 months for injectable semaglutide stands at 84 per cent, compared with just 46 per cent for the oral formulation. This significant difference in treatment adherence plays an important role in the overall outcome in the long term.

A weekly injection also requires less daily discipline than a tablet, where the time of intake and fasting are crucial to its effectiveness. Those who keep the barrier to taking the injection low by linking it to a fixed day of the week generally find the practical burden to be minimal.

Are the side effects different for oral and injectable semaglutide?

The side effects overlap to a large extent. Both forms cause gastrointestinal symptoms such as nausea, diarrhoea, vomiting and constipation, particularly during the build-up phase. Serious but rare side effects such as acute pancreatitis and kidney failure occur with both forms. Read more about the side effects of semaglutide for a complete overview.

However, there are two relevant differences. The tablet is more likely to cause local gastrointestinal discomfort, as the active ingredient is absorbed in the stomach rather than subcutaneously, and higher doses of Rybelsus are associated with more dysgeusia (taste disturbances). In some users, the injection causes a reaction at the injection site, such as redness or slight swelling. A 12-month study shows that injectable semaglutide results in greater weight loss, particularly in men, which indirectly also affects the side-effect profile at higher doses.

What does Goodweigh offer?

Goodweigh provides medical guidance regarding treatment with semaglutide via an online consultation with one of our doctors. Based on your medical history, your preferences and your weight loss goal, the doctor will advise you on which form is most suitable. We therefore always take an individual approach to determine whether the tablet or the injection is the best choice for you.

Following the initial consultation, Goodweigh will arrange the prescriptions, and the medication will be delivered discreetly to your door. Throughout the programme, you’ll stay in touch with your doctor: dosage adjustments and any side effects are also monitored, so you’re never left to manage things on your own. A 12-month study shows that guidance and consistent treatment are crucial for ultimate weight loss, regardless of which form of semaglutide you use.

The right form of semaglutide: find it with Goodweigh

Both oral and injectable semaglutide have been shown to be effective for weight loss. On average, the injection delivers better results and higher long-term treatment adherence. The tablet is a perfectly valid alternative for those who do not wish to have injections, provided that the strict instructions for taking it are followed. You should decide which form is best for you in consultation with a doctor. Book an initial consultation via Goodweigh and start your programme in a medically responsible way.

‍

‍

‍